A high-tech kabuki theatre, dedicated to the 400-year-old stylised kabuki-za performing art in Japan, is set to open in a 29-storey Tokyo office building in Tokyo's upscale Ginza shopping district next month.
The soon-to-be-opened kabuki theatre will be the fifth version of the theatre, and will boast the incorporation of some noteworthy high-tech fixes into the venue. Housed in the tallest skyscraper in the Ginza shopping district, the new theatre - with a history dating back to 1889 - will have four storeys.
According to the information shared by the theatre managers, the theatre - which will retain most of the elements of the original interior as well as the facade - will have the capacity to seat 1,800 people. There will be portable monitors to be used by the audience for reading subtitles which will explain the art form that, at times, is somewhat difficult to understand.
Initially, the `subtitles' service will be available only in the Japanese language; but, gradually, over the coming months, the service will be extended to include foreign language, starting with English.
One of the other attractions of the theatre is a 16.45 metre (54 feet) deep pit below the stage. The pit - which is four times bigger than the earlier pits - will essentially facilitate the emergence of props, actors and scenery from the bowels of the building.
According to recent rumors as well as insider tips, Microsoft will likely unveil a ‘Slim’ model of its Xbox One game console at the 2016 Electronic Entertainment Expo (E3) in Los Angeles.
The new Xbox One ‘Slim’ model will reportedly be...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
Chinese device manufacturer Lenovo officially unveiled...
Motorola’s newest flagship devices -- the Moto Z and the...
In an announcement made on Thursday, electric vehicle...
The Verge has revealed in a Wednesday report, citing a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).